VENTANA FOLR1 (FOLR-2.1) RxDx Assay
FDA premarket approval P220006 · decided 2022-11-14
Approval details
- PMA number
- P220006
- Trade name
- VENTANA FOLR1 (FOLR-2.1) RxDx Assay
- Generic name
- Immunohistochemistry Assay, Antibody, FOLR1
- Applicant
- Ventana Medical Systems, Inc.
- Date received
- 2022-04-25
- Decision date
- 2022-11-14
- Days to decision
- 203 days
- Decision code
- APPR
- Product code
- QUL
- Advisory committee
- Medical Genetics
- Expedited review
- No
- Location
- Tucson, AZ
- Statement
- Approval for the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay. The device is a qualitative immunohistochemical assay using mouse monoclonal anti-FOLR1, clone FOLR1-2.1, intended for use in the assessment of folate receptor alpha (FOLR1) protein in formalin-fixed, paraffin-embedded epithelial ovarian, fallopian tube or primary peritoneal cancer tissue specimens by light microscopy. This assay is for use with OptiView DAB IHC Detection Kit for staining on a BenchMark ULTRA instrument.FOLR1 expression clin
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Roche Digital Pathology Dx (K242783) | Ventana Medical Systems, Inc. | 2024-12-17 |
| VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001) (DEN240025) | Ventana Medical Systems, Inc. | 2024-12-05 |
| Roche Digital Pathology Dx (VENTANA DP 200) (K232879) | Ventana Medical Systems, Inc. | 2024-06-14 |
| CINtec Histology (K212176) | Ventana Medical Systems, Inc. | 2021-12-10 |
| VENTANA CD30 (Ber-H2) RxDx Assay (K172471) | Ventana Medical Systems, Inc. | 2018-05-08 |
| CINtec Histology (50 tests), CINtec Histology (250 tests) (DEN160019) | Ventana Medical Systems, Inc. | 2017-03-04 |
| Virtuoso System for IHC PR (1E2) using iScan HT (K142965) | Ventana Medical Systems, Inc. | 2015-07-16 |
| VIRTUOSO SYSTEM FOR IHC ER (SP1) WITH BENCHMARK ULTRA STAINER (K140465) | Ventana Medical Systems, Inc. | 2014-03-20 |